$ODC

Smart Money Move: Wade Walter Robey Grabs $295K Worth Of Oil-Dri Corp of America Stock - Oil-Dri Corp of America (NYSE:ODC)

A significant insider buy by Wade Walter Robey, VP at Oil-Dri Corp of America ( NYSE:ODC ) , was executed on October 21, and reported in the recent SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Robey purchased 5,000 shares ...

Original reporting
Benzinga · Benzinga Insights
Published Oct 22, 2025, 3:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2025, 4:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Smart Money Move: Wade Walter Robey Grabs $295K Worth Of Oil-Dri Corp of America Stock - Oil-Dri Corp of America (NYSE:ODC) — source image
Decision brief

The 30-second read

$ODCBullishMed
01

Why it matters

This insider activity may signal an undervalued stock or positive outlook, potentially leading to short-term price appreciation.

02

Market read

The insider purchase is relevant for traders focusing on small to mid-cap manufacturing stocks, especially those with insider activity.

03

What to watch

Broader industry trends, company fundamentals, and recent earnings reports should be considered before acting.

Timing: Immediate, as the insider purchase was executed on October 21.

Background

Wade Walter Robey, VP at Oil-Dri, executed a significant purchase of 5,000 shares, indicating insider confidence.

Company-level read

Ticker impact

$ODCBullishMedium confidence
Context

The insider purchase by Wade Walter Robey indicates a potential positive sentiment towards Oil-Dri Corp of America (NYSE: ODC).

Expected impact

Moderate upward movement in the short to medium term, approximately 3-5%.

Evidence & confidence

Insider buying is generally viewed as a positive signal, but it is a single data point. No significant technical breakout observed, and broader market conditions should be considered.

Market effects

Potential positive impact on the manufacturing and industrial sectors due to increased insider confidence.

Limited, as the news pertains specifically to a U.S.-listed company.

Minimal, as the event is company-specific and not indicative of broader global trends.

Counterpoint

Insider buying does not guarantee stock appreciation; it could be a strategic move with no immediate impact.

Key entities

  • Oil-Dri Corp of America

    A manufacturer of absorbent products for the consumer, industrial, and agricultural markets.

  • Wade Walter Robey

    Vice President at Oil-Dri Corp of America, recent insider buyer.

Related articles

$ODCMed

Oil-Dri Corp of America (ODC): Results of Operations and Financial Condition

Oil-Dri Corp of America (ODC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 odcf26q3ex991-earningsrele.htm EX-99.1 Document 410 N. Michigan Ave. Chicago, Illinois 60611, U.S.A News Announcement For Immediate Release Exhibit 99.1 Oil-Dri Reports Record Third Quarter Revenues and Strong Earnings Growth CHICAGO-(June 8, 2026) - Oil-Dri Corporation

$CLMed

Piper Sandler cuts Colgate-Palmolive stock price target on cost pressures

Piper Sandler reduced its price target for Colgate-Palmolive (CL) to $95 from $98, citing cost pressures from elevated oil prices and inventory headwinds. The firm maintained an Overweight rating and a 2026 EPS estimate of $3.85, but lowered its 2027 EPS estimate to $4.12 from $4.23. CL trades at $87.47 with a P/E ratio of 34.6 and a gross profit margin of 60%. Other analysts have maintained positive outlooks, with RBC and UBS setting higher price targets.

$DYMed

KeyBanc raises Dycom Industries stock price target on growth outlook

KeyBanc raised its price target for Dycom Industries (NYSE:DY) to $429 from $423, citing growth outlook and meetings with management. The stock is down 48% from its 52-week high but is considered undervalued. Other analysts have mixed views, with UBS reiterating a Buy rating and Raymond James lowering its target. Dycom reported 38% revenue growth over the last year.

MedAI 8/10

85% of Nscale’s $103B of contracts are with Microsoft and Anthropic

Nscale revealed that 85% of its $103B contracts are with Microsoft (MSFT) and Anthropic, including $43.8B with MSFT and $44.6B with Anthropic. The company acknowledged concentration risk and reported a net loss of $1.02B on $140.6M sales for H1. Nvidia (NVDA) is a major shareholder and supplier. Nscale aims for a $35B valuation in its upcoming IPO.